These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 43241)

  • 1. Altered activation of tyrosine hydroxylation by gamma-butyrolactone following chronic ethanol treatment.
    Liljequist S
    Drug Alcohol Depend; 1979; 4(3-4):261-3. PubMed ID: 43241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone.
    Sved A; Fernstrom J
    Life Sci; 1981 Aug; 29(7):743-8. PubMed ID: 6792441
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration.
    Liljequist S; Engel J
    J Neural Transm; 1979; 46(3):195-204. PubMed ID: 528994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered response to cessation of nerve impulse flow in dopamine neurons after chronic ethanol administration.
    Liljequist S; Engel J
    Adv Exp Med Biol; 1980; 126():157-63. PubMed ID: 6773305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.
    Nowycky MC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):247-54. PubMed ID: 43476
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonstriatal dopaminergic neurons: role of presynaptic receptors in the modulation of transmitter synthesis.
    Roth RH; Nowycky MC
    Adv Biochem Psychopharmacol; 1977; 16():465-70. PubMed ID: 18895
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 9. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
    Murrin LC; Roth RH
    Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R; Young D; Newbould E; Jaskiw GE
    Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M
    Ann N Y Acad Sci; 1984; 430():1-5. PubMed ID: 6146282
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in receptors controlling dopamine synthesis after chronic ethanol ingestion.
    Tabakoff B; Hoffman PL
    J Neurochem; 1978 Nov; 31(5):1223-9. PubMed ID: 29948
    [No Abstract]   [Full Text] [Related]  

  • 14. The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
    Haubrich DR; Pflueger AB
    Mol Pharmacol; 1982 Jan; 21(1):114-20. PubMed ID: 6127616
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endovenous dopamine after cessation of impulse flow.
    Walters JR; Roth RH
    Biochem Pharmacol; 1976 Mar; 25(6):649-54. PubMed ID: 6034
    [No Abstract]   [Full Text] [Related]  

  • 16. Adaptive changes in the dopamine system produced by chronic ethanol feeding.
    Hoffman PL; Tabakoff B
    Drug Alcohol Depend; 1979; 4(3-4):255-60. PubMed ID: 43240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP; Wolf ME; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY; Garcia-Espana A; Lee KY; Carr KD; Goldstein M; Haycock JW; Meller E
    Mol Pharmacol; 1999 Feb; 55(2):202-9. PubMed ID: 9927609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of gamma-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis.
    Kuczenski R
    J Neurochem; 1978 Jul; 31(1):347-9. PubMed ID: 671029
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone.
    Dyck LE; Kazakoff CW
    J Neurosci Res; 1982; 8(1):57-65. PubMed ID: 7175978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.